1. Home
  2. Biosimilars als Arzneimittel. Ein Überblick über die Chancen und Risiken
  • #

Biosimilars als Arzneimittel. Ein Überblick über die Chancen und Risiken

15.95 EUR

Teilen:
Gesponsert

Biosimilars als Arzneimittel. Ein Überblick über die Chancen und Risiken

Medimops DE
15.95 EUR
30-04-2026 19:13:27

Ähnliche Produkte

Rift-lines within european regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and ... BIOLOGIC AND THE BIOSIMILAR INTO ACCOUNT

Rift-lines within european regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and ... BIOLOGIC AND THE BIOSIMILAR INTO ACCOUNT

54.99 EUR
Rift-lines within European regulatory framework for Biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account

Rift-lines within European regulatory framework for Biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account

54.99 EUR
Biosimilars

Biosimilars

124.14 EUR
Biosimilars: A New Generation of Biologics

Biosimilars: A New Generation of Biologics

126.14 EUR
Introduction to Biologic and Biosimilar Product Development and Analysis

Introduction to Biologic and Biosimilar Product Development and Analysis

117.69 EUR
Strategy to Commercialize Biosimilar in European Union

Strategy to Commercialize Biosimilar in European Union

65.54 EUR